Finn Lilleås

1.9k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Finn Lilleås is a scholar working on Pathology and Forensic Medicine, Rheumatology and Oncology. According to data from OpenAlex, Finn Lilleås has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 7 papers in Rheumatology and 6 papers in Oncology. Recurrent topics in Finn Lilleås's work include Multiple Sclerosis Research Studies (9 papers), Systemic Lupus Erythematosus Research (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Finn Lilleås is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Systemic Lupus Erythematosus Research (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Finn Lilleås collaborates with scholars based in Norway and Denmark. Finn Lilleås's co-authors include Tom Amundsen, Michael Abdelnoor, Henrik Weber, Bjørn Magnæs, B Magnaes, Kjell‐Morten Myhr, S. J. Bakke, Rune Midgard, Stig Wergeland and Kristian S. Bjerve and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Bone and Joint Surgery.

In The Last Decade

Finn Lilleås

21 papers receiving 1.4k citations

Hit Papers

Lumbar Spinal Stenosis: Conservative or Surgical Management? 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Finn Lilleås Norway 15 1.1k 660 586 159 151 22 1.4k
Luigi Aurelio Nasto Italy 20 701 0.6× 830 1.3× 341 0.6× 99 0.6× 89 0.6× 78 1.7k
Kentaro Yamada Japan 20 365 0.3× 724 1.1× 110 0.2× 201 1.3× 72 0.5× 85 1.4k
Dalong Yang China 24 1.1k 1.0× 1.1k 1.7× 316 0.5× 16 0.1× 122 0.8× 106 1.6k
Shunji Kishida Japan 23 544 0.5× 694 1.1× 441 0.8× 11 0.1× 133 0.9× 68 1.4k
Cora Bow Hong Kong 19 439 0.4× 528 0.8× 285 0.5× 14 0.1× 142 0.9× 37 1.0k
Hideyuki Arima Japan 22 902 0.8× 1.4k 2.1× 180 0.3× 22 0.1× 85 0.6× 152 1.8k
Xiaolong Chen China 19 469 0.4× 357 0.5× 282 0.5× 38 0.2× 73 0.5× 113 985
Eric Lorenz Germany 18 314 0.3× 851 1.3× 93 0.2× 41 0.3× 193 1.3× 45 1.3k
Guangzhi Ning China 18 482 0.4× 349 0.5× 77 0.1× 43 0.3× 48 0.3× 28 1.1k

Countries citing papers authored by Finn Lilleås

Since Specialization
Citations

This map shows the geographic impact of Finn Lilleås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn Lilleås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn Lilleås more than expected).

Fields of papers citing papers by Finn Lilleås

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finn Lilleås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn Lilleås. The network helps show where Finn Lilleås may publish in the future.

Co-authorship network of co-authors of Finn Lilleås

This figure shows the co-authorship network connecting the top 25 collaborators of Finn Lilleås. A scholar is included among the top collaborators of Finn Lilleås based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finn Lilleås. Finn Lilleås is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Myhr, Kjell‐Morten, Trygve Holmøy, Jūratė Šaltytė Benth, et al.. (2016). No association of tobacco use and disease activity in multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 3(4). e260–e260. 19 indexed citations
2.
Røsjø, Egil, Kjell‐Morten Myhr, Kristin I. Løken-Amsrud, et al.. (2015). Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 280. 21–28. 14 indexed citations
3.
Myhr, Kjell‐Morten, Trygve Holmøy, Jūratė Šaltytė Benth, et al.. (2015). Body mass index influence interferon-beta treatment response in multiple sclerosis. Journal of Neuroimmunology. 288. 92–97. 50 indexed citations
4.
Røsjø, Egil, Kjell‐Morten Myhr, Kristin I. Løken-Amsrud, et al.. (2014). Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. Journal of Neuroimmunology. 271(1-2). 60–65. 14 indexed citations
5.
Myhr, Kjell‐Morten, Trygve Holmøy, S. J. Bakke, et al.. (2014). Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis. Multiple Sclerosis Journal. 20(14). 1833–1840. 57 indexed citations
6.
Holmøy, Trygve, Kristin I. Løken-Amsrud, S. J. Bakke, et al.. (2013). Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity. PLoS ONE. 8(9). e75021–e75021. 29 indexed citations
7.
Løken-Amsrud, Kristin I., Kjell‐Morten Myhr, S. J. Bakke, et al.. (2013). Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction. PLoS ONE. 8(1). e54417–e54417. 21 indexed citations
8.
Løken-Amsrud, Kristin I., Trygve Holmøy, S. J. Bakke, et al.. (2012). Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment. Neurology. 79(3). 267–273. 90 indexed citations
9.
Torkildsen, Øivind, Stig Wergeland, S. J. Bakke, et al.. (2012). ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study). Archives of Neurology. 69(8). 1044–51. 110 indexed citations
10.
Løken-Amsrud, Kristin I., Kjell‐Morten Myhr, S. J. Bakke, et al.. (2012). Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Multiple Sclerosis Journal. 19(4). 451–457. 42 indexed citations
11.
Bakke, S. J., et al.. (2003). Bruk av MR i diagnostikk av multippel sklerose. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
12.
Ørstavik, Ragnhild, Glenn Haugeberg, Till Uhlig, et al.. (2003). Vertebral deformities in 229 female patients with rheumatoid arthritis: Associations with clinical variables and bone mineral density. Arthritis Care & Research. 49(3). 355–360. 41 indexed citations
13.
Amundsen, Tom, et al.. (2000). Lumbar Spinal Stenosis: Conservative or Surgical Management?. Spine. 25(11). 1424–1436. 500 indexed citations breakdown →
14.
Skjeldal, S., Finn Lilleås, Gunnar Follerås, et al.. (2000). Real time MRI-guided excision and cryo-treatment of osteoid osteoma in os ischii--a case report. Acta Orthopaedica Scandinavica. 71(6). 637–638. 40 indexed citations
15.
Ørstavik, Ragnhild, Glenn Haugeberg, Tore K Kvien, & Finn Lilleås. (2000). [Vertebral fractures in osteoporosis--silent fractures of clinical importance].. PubMed. 120(24). 2891–4. 3 indexed citations
16.
Myhr, Kjell‐Morten, Trond Riise, Finn Lilleås, et al.. (1999). Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Neurology. 52(5). 1049–1049. 42 indexed citations
17.
Amundsen, Tom, et al.. (1995). Lumbar Spinal Stenosis. Spine. 20(10). 1178–1186. 301 indexed citations
18.
Mair, I. W. S., et al.. (1994). Cavernous hemangioma of the middle ear.. PubMed. 15(2). 254–6. 5 indexed citations
19.
Djupesland, G., et al.. (1992). Palatopharyngoglossoplasty in the Treatment of Patients with Obstructive Sleep Apnea Syndrome. Acta Oto-Laryngologica. 112(sup492). 50–54. 23 indexed citations
20.
Keene, James S., et al.. (1982). Diagnosis of vertebral fractures. A comparison of conventional radiography, conventional tomography, and computed axial tomography.. Journal of Bone and Joint Surgery. 64(4). 586–594. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026